These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32125204)

  • 1. Evaluation of the patients diagnosed as idiopathic intracranial hypertension with and without papilledema visual pathways by analysis of visual evoked potential.
    Kisabay A; Selcuki D; Zeybek S; Batum M
    Int J Neurosci; 2021 Feb; 131(2):183-190. PubMed ID: 32125204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiological visual assessment in patients with idiopathic intracranial hypertension: visual evoked potential and multifocal field electroretinography.
    Elgaly MA; Hosny H; El Habashy HR; Hussein M; Magdy R; Elanwar R
    BMC Neurol; 2023 May; 23(1):188. PubMed ID: 37165341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension.
    Skau M; Yri H; Sander B; Gerds TA; Milea D; Jensen R
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):567-74. PubMed ID: 22592348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal damage in papilledema linked to idiopathic intracranial hypertension as revealed by multifocal visual evoked potentials.
    Hartmann CJ; Klistorner AI; Brandt AU; Schroeder K; Kolbe R; Cohn E; Goebels N; Guthoff R; Aktas O; Hartung HP; Albrecht P
    Clin Neurophysiol; 2015 Oct; 126(10):2040-1. PubMed ID: 25613033
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term evolution of papilledema in idiopathic intracranial hypertension: observations concerning two cases.
    Piovesan EJ; Lange MC; Piovesan Ldo R; de Almeida SM; Kowacs PA; Werneck LC
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):453-7. PubMed ID: 12131949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Intracranial Pressure Monitoring for Diagnosis of Idiopathic Intracranial Hypertension in the Absence of Papilledema.
    Bridges KJ; Raslan AM
    World Neurosurg; 2018 Mar; 111():e221-e227. PubMed ID: 29258930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IIH with normal CSF pressures?
    Suh SY; Kim SJ
    Indian J Ophthalmol; 2013 Nov; 61(11):681-2. PubMed ID: 24145570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilament light chain marks severity of papilledema in idiopathic intracranial hypertension.
    Knoche T; Gaus V; Haffner P; Kowski A
    Neurol Sci; 2023 Jun; 44(6):2131-2135. PubMed ID: 36689008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
    Vosoughi AR; Margolin EA; Micieli JA
    J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual evoked potentials follow-up in idiopathic intracranial hypertension.
    Hamamci M; Tombul T
    Neurosciences (Riyadh); 2019 Jul; 24(3):185-191. PubMed ID: 31380817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Intracranial Hypertension in a pubertal paediatric Indian patient.
    Aggarwal A; Kaur P; Chhabra K; Singh K; Goyal P
    Nepal J Ophthalmol; 2017 Jan; 9(18):74-78. PubMed ID: 29022960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optic Nerve Angle in Idiopathic Intracranial Hypertension.
    Chen BS; Asnafi S; Lin MY; Bruce BB; Lock JH; Sharma RA; Newman NJ; Biousse V; Saindane AM
    J Neuroophthalmol; 2021 Dec; 41(4):e464-e469. PubMed ID: 34788243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between papilledema grade and diffusion-weighted magnetic resonance imaging in idiopathic intracranial hypertension.
    Salvay DM; Padhye LV; Huecker JB; Gordon MO; Viets R; Sharma A; Van Stavern GP
    J Neuroophthalmol; 2014 Dec; 34(4):331-5. PubMed ID: 25000261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
    Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
    Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal Manifestations of Idiopathic Intracranial Hypertension.
    Nichani P; Micieli JA
    Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema.
    Farrokhi Y; Sharif Kashani S; Aghsaei Fard M; Pakdel F; Yadegari S
    Clin Neurol Neurosurg; 2019 Sep; 184():105376. PubMed ID: 31176474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension.
    Bidot S; Clough L; Saindane AM; Newman NJ; Biousse V; Bruce BB
    J Neuroophthalmol; 2016 Jun; 36(2):120-5. PubMed ID: 26580295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papilledema: A review of etiology, pathophysiology, diagnosis, and management.
    Xie JS; Donaldson L; Margolin E
    Surv Ophthalmol; 2022; 67(4):1135-1159. PubMed ID: 34813854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presumptive Idiopathic Intracranial Hypertension Based on Neuroimaging Findings: A Referral Pattern Study.
    Aung AB; Chen BS; Wicks J; Bruce BB; Meyer BI; Dattilo M; Kedar S; Saindane A; Newman NJ; Biousse V
    J Neuroophthalmol; 2023 Mar; 43(1):55-62. PubMed ID: 36166790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of idiopathic intracranial hypertension with and without papilledema.
    Digre KB; Nakamoto BK; Warner JE; Langeberg WJ; Baggaley SK; Katz BJ
    Headache; 2009 Feb; 49(2):185-93. PubMed ID: 19222592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.